EVOTEC AG O.N.

Premiumpartner

Firmenbeschreibung

Die Evotec SE zählt zu den weltweit führenden Wirkstoffforschungs- und -entwicklungsunternehmen. Die Firma ist auf neurale Erkrankungen, Schmerz, Stoffwechsel- und Entzündungskrankheiten sowie Onkologie spezialisiert. Das Kerngeschäft bildet die Wirkstoffforschung, die in Kooperation mit Partnerunternehmen aus der Pharma- und Biotechnologieindustrie realisiert wird. Unternehmen, die ihre Wirkstoffentwicklung auslagern wollen, werden hochwertige Lösungen und Dienstleistungen in diesem Bereich angeboten. Evotec übernimmt dabei alle Aktivitäten bis hin zur klinischen Entwicklung. Das Unternehmen unterhält langjährige Forschungsallianzen mit den größten Pharma-Unternehmen wie Bayer, Boehringer Ingelheim, Bristol Myers Squibb, CHDI, Novartis, Novo Nordisk, Pfizer, Sanofi oder Takeda sowie mit der Havard University zur Erforschung neuer Wirkstoffe.

KeyData

endOfFinancialYear: 31.12.2022 00:00
stockholderStructure: T. Rowe Price Group (10%),Novo Holdings A/S (10%),Mubadala Investment Company (7%)
sharesOutstanding: 176916663.0000
ceo: Dr Christian Wojczewski
board: Laetitia Rouxel, Dr. Cord Dohrmann, Dr. Craig Johnstone, Dr. Matthias Evers, Aurélie Dalbiez
supervisoryBoard: Prof. Dr. Iris Löw-Friedrich, Dr. Constanze Ulmer-Eilfort, Roland Sackers, Camilla Macapili Languille, Dr. Duncan McHale, Wes Wheeler
countryID: 2
freeFloat: 62.1900
faceValueCurrencyID: 1
faceValueCurrency: EUR
sectorName: Biotechnologie
industryName: Biotechnologie
subsectorName: Biotechnologie
country: Deutschland
countryName: Deutschland

Kontakt

name: Volker Braun
phone: +49-40-56081-775
fax: +49-40-56081-222
email: InvestorRelations@evotec.com
irWebSite: https://www.evotec.com/en/investor-relations

Adresse

street: Essener Bogen 7
city: D-22419 Hamburg
phone: +49-40-56081-0
fax: +49-40-56081-222
webSite: www.evotec.com
email: info@evotec.com

Finanzen (kurz)

year: 2021 cash: 699.3000
balanceSheetTotal: 2235.2000 liabilities: 857.5000
totalShareholdersEquity: 1377.7000 sales: 618.0000
bankLoans: 41.0000 investment: 2.3000
incomeBeforeTaxes: 237.0000 netIncome: 215.5000
cashFlow: 276.8000 employees: 3945
currencyID: 1 units: 1000000
currency: EUR
year: 2022 cash: 415.1600
balanceSheetTotal: 2257.2500 liabilities: 1070.0600
totalShareholdersEquity: 1187.1800 sales: 751.4500
investment: 8.3400 incomeBeforeTaxes: -153.9600
netIncome: -175.6600 employees: 4952
currencyID: 1 units: 1000000
currency: EUR
year: 2023 cash: 510.9090
balanceSheetTotal: 2252.4680 liabilities: 1132.5600
totalShareholdersEquity: 1119.9080 sales: 781.4260
investment: 9.2630 incomeBeforeTaxes: -80.5930
netIncome: -83.9130 employees: 5061
currencyID: 1 units: 1000000
currency: EUR

Finanzen (kurz)

year: 2021
cash: 699.3000
balanceSheetTotal: 2235.2000
liabilities: 857.5000
totalShareholdersEquity: 1377.7000
sales: 618.0000
bankLoans: 41.0000
investment: 2.3000
incomeBeforeTaxes: 237.0000
netIncome: 215.5000
cashFlow: 276.8000
employees: 3945
currencyID: 1
units: 1000000
currency: EUR
year: 2022
cash: 415.1600
balanceSheetTotal: 2257.2500
liabilities: 1070.0600
totalShareholdersEquity: 1187.1800
sales: 751.4500
investment: 8.3400
incomeBeforeTaxes: -153.9600
netIncome: -175.6600
employees: 4952
currencyID: 1
units: 1000000
currency: EUR
year: 2023
cash: 510.9090
balanceSheetTotal: 2252.4680
liabilities: 1132.5600
totalShareholdersEquity: 1119.9080
sales: 781.4260
investment: 9.2630
incomeBeforeTaxes: -80.5930
netIncome: -83.9130
employees: 5061
currencyID: 1
units: 1000000
currency: EUR

Finanzen (ausführlich)

year: 2022 units: 1000000
balanceSheetTotal: 2257.2500 cash: 415.1600
currentAssets: 1073.6700 fixedAssets: 1183.5800
liabilities: 337.7100 nonCurrentLiabilities: 732.3600
totalLiabilitiesEquity: 2257.2500 provisions: 89.3600
totalShareholdersEquity: 1187.1800 employees: 4952
property: 650.2000 intangibleAssets: 23.8200
longTermInvestments: 147.1000 inventories: 29.8300
accountsReceivable: 168.6500 accountsPayable: 97.2800
liabilitiesTotal: 1070.0600 longTermDebt: 490.2900
shortTermDebt: 16.3800 minorityInterests: 0.0000
sales: 751.4500 netIncome: -175.6600
operatingResult: 20.8500 incomeInterest: -4.8100
investments: 76.6400 incomeTaxes: 21.7000
costGoodsSold: 577.3800 grossProfit: 174.1000
revenuePerEmployee: 151746.7690 cashFlow: 203.1100
cashFlowInvesting: -415.8200 cashFlowFinancing: -52.4100
accountingStandard: IFRS equityRatio: 52.5941
debtEquityRatio: 90.1354 liquidityI: 122.9339
liquidityII: 172.8732 netMargin: -23.3761
grossMargin: 23.1685 cashFlowMargin: 27.0291
ebitMargin: 2.7746 ebitdaMargin: 0.0000
preTaxROE: -12.9685 preTaxROA: -6.8207
roe: -14.7964 roa: -7.7820
netIncomeGrowth: -181.5128 revenuesGrowth: 21.5939
taxExpenseRate: -14.0946 equityTurnover: 0.6330
epsBasic: -0.9900 epsBasicGrowth: -176.1538
incomeBeforeTaxes: -153.9600 priceCashFlowRatio: 13.2948
bookValuePerShare: 6.7090 marketCap: 2700297484.7800
earningsYield: -6.4875 cashFlowPerShare: 1.1478
netAssetsPerShare: 6.7090 priceBookValueRatio: 2.2745
netEarningsPerShare: -0.9927 currency: EUR
year: 2023 units: 1000000
balanceSheetTotal: 2252.4680 cash: 510.9090
currentAssets: 903.1620 fixedAssets: 1349.3060
liabilities: 464.5730 nonCurrentLiabilities: 667.9870
totalLiabilitiesEquity: 2252.4680 provisions: 79.3650
totalShareholdersEquity: 1119.9080 employees: 5061
property: 806.5630 intangibleAssets: 15.4530
longTermInvestments: 142.0940 inventories: 30.8900
accountsReceivable: 98.3960 accountsPayable: 134.3190
liabilitiesTotal: 1132.5600 longTermDebt: 477.1120
shortTermDebt: 149.0960 minorityInterests: 0.0000
sales: 781.4260 netIncome: -83.9130
operatingResult: -47.5070 incomeInterest: -2.4760
investments: 68.5290 incomeTaxes: 3.3200
costGoodsSold: 606.3750 grossProfit: 175.0510
minorityInterestsProfit: 0.0000 revenuePerEmployee: 154401.5017
cashFlow: 36.4390 cashFlowInvesting: -13.2910
cashFlowFinancing: 71.9630 accountingStandard: IFRS
equityRatio: 49.7192 debtEquityRatio: 101.1297
liquidityI: 109.9739 liquidityII: 131.1538
netMargin: -10.7384 grossMargin: 22.4015
cashFlowMargin: 4.6631 ebitMargin: -6.0795
ebitdaMargin: 0.0000 preTaxROE: -7.1964
preTaxROA: -3.5780 roe: -7.4928
roa: -3.7254 netIncomeGrowth: -52.2299
revenuesGrowth: 3.9891 taxExpenseRate: -4.1195
equityTurnover: 0.6978 epsBasic: -0.4700
epsBasicGrowth: -52.5253 incomeBeforeTaxes: -80.5930
priceCashFlowRatio: 103.3175 bookValuePerShare: 6.3301
marketCap: 3764786588.6400 earningsYield: -2.2086
cashFlowPerShare: 0.2060 netAssetsPerShare: 6.3301
priceBookValueRatio: 3.3617 netEarningsPerShare: -0.4743
currency: EUR
year: 2024 priceCashFlowRatio: 41.4387
bookValuePerShare: 6.3301 marketCap: 1509983718.7050
earningsYield: -5.5067 pegRatio: 0.3457
cashFlowPerShare: 0.2060 netAssetsPerShare: 6.3301
priceBookValueRatio: 1.3483 netEarningsPerShare: -0.4743
currency: EUR

Finanzen (ausführlich)

year: 2022
units: 1000000
balanceSheetTotal: 2257.2500
cash: 415.1600
currentAssets: 1073.6700
fixedAssets: 1183.5800
liabilities: 337.7100
nonCurrentLiabilities: 732.3600
totalLiabilitiesEquity: 2257.2500
provisions: 89.3600
totalShareholdersEquity: 1187.1800
employees: 4952
property: 650.2000
intangibleAssets: 23.8200
longTermInvestments: 147.1000
inventories: 29.8300
accountsReceivable: 168.6500
accountsPayable: 97.2800
liabilitiesTotal: 1070.0600
longTermDebt: 490.2900
shortTermDebt: 16.3800
minorityInterests: 0.0000
sales: 751.4500
netIncome: -175.6600
operatingResult: 20.8500
incomeInterest: -4.8100
investments: 76.6400
incomeTaxes: 21.7000
costGoodsSold: 577.3800
grossProfit: 174.1000
revenuePerEmployee: 151746.7690
cashFlow: 203.1100
cashFlowInvesting: -415.8200
cashFlowFinancing: -52.4100
accountingStandard: IFRS
equityRatio: 52.5941
debtEquityRatio: 90.1354
liquidityI: 122.9339
liquidityII: 172.8732
netMargin: -23.3761
grossMargin: 23.1685
cashFlowMargin: 27.0291
ebitMargin: 2.7746
ebitdaMargin: 0.0000
preTaxROE: -12.9685
preTaxROA: -6.8207
roe: -14.7964
roa: -7.7820
netIncomeGrowth: -181.5128
revenuesGrowth: 21.5939
taxExpenseRate: -14.0946
equityTurnover: 0.6330
epsBasic: -0.9900
epsBasicGrowth: -176.1538
incomeBeforeTaxes: -153.9600
priceCashFlowRatio: 13.2948
bookValuePerShare: 6.7090
marketCap: 2700297484.7800
earningsYield: -6.4875
cashFlowPerShare: 1.1478
netAssetsPerShare: 6.7090
priceBookValueRatio: 2.2745
netEarningsPerShare: -0.9927
currency: EUR
year: 2023
units: 1000000
balanceSheetTotal: 2252.4680
cash: 510.9090
currentAssets: 903.1620
fixedAssets: 1349.3060
liabilities: 464.5730
nonCurrentLiabilities: 667.9870
totalLiabilitiesEquity: 2252.4680
provisions: 79.3650
totalShareholdersEquity: 1119.9080
employees: 5061
property: 806.5630
intangibleAssets: 15.4530
longTermInvestments: 142.0940
inventories: 30.8900
accountsReceivable: 98.3960
accountsPayable: 134.3190
liabilitiesTotal: 1132.5600
longTermDebt: 477.1120
shortTermDebt: 149.0960
minorityInterests: 0.0000
sales: 781.4260
netIncome: -83.9130
operatingResult: -47.5070
incomeInterest: -2.4760
investments: 68.5290
incomeTaxes: 3.3200
costGoodsSold: 606.3750
grossProfit: 175.0510
minorityInterestsProfit: 0.0000
revenuePerEmployee: 154401.5017
cashFlow: 36.4390
cashFlowInvesting: -13.2910
cashFlowFinancing: 71.9630
accountingStandard: IFRS
equityRatio: 49.7192
debtEquityRatio: 101.1297
liquidityI: 109.9739
liquidityII: 131.1538
netMargin: -10.7384
grossMargin: 22.4015
cashFlowMargin: 4.6631
ebitMargin: -6.0795
ebitdaMargin: 0.0000
preTaxROE: -7.1964
preTaxROA: -3.5780
roe: -7.4928
roa: -3.7254
netIncomeGrowth: -52.2299
revenuesGrowth: 3.9891
taxExpenseRate: -4.1195
equityTurnover: 0.6978
epsBasic: -0.4700
epsBasicGrowth: -52.5253
incomeBeforeTaxes: -80.5930
priceCashFlowRatio: 103.3175
bookValuePerShare: 6.3301
marketCap: 3764786588.6400
earningsYield: -2.2086
cashFlowPerShare: 0.2060
netAssetsPerShare: 6.3301
priceBookValueRatio: 3.3617
netEarningsPerShare: -0.4743
currency: EUR
year: 2024
priceCashFlowRatio: 41.4387
bookValuePerShare: 6.3301
marketCap: 1509983718.7050
earningsYield: -5.5067
pegRatio: 0.3457
cashFlowPerShare: 0.2060
netAssetsPerShare: 6.3301
priceBookValueRatio: 1.3483
netEarningsPerShare: -0.4743
currency: EUR